ad image

AOBiome

1 / 1
AOBiome Therapeutics, Inc.
Clinical Trials

AOBiome Doses First Patient in Phase 1b Clinical Trial of B244 for the Treatment of Pediatric Atopic Dermatitis

AOBiome Therapeutics, Inc.

PR-M03-19-NI-022Mar 08, 2019
AOBiome Therapeutics, Inc.
Appointment

AOBiome Therapeutics Announces Appointment of Dr. Judith Ng Cashin as Chief Medical Officer

AOBiome Therapeutics, Inc.

PR-M12-18-NI-074Dec 21, 2018
1 / 1